Table 1.
Sleep variable | Comparator (C) Mean ± SEM | Baseline (B) Mean ± SEM | Intervention (I) Mean ± SEM | p | C vs. B | C vs. I |
---|---|---|---|---|---|---|
Total sleep time (min) | 476.67 ± 17.32 | 397.67 ± 18.67 | 437.78 ± 14.37 | 0.0107 | 0.0067 | 0.2375 |
Sleep efficiency (%) | 91.42 ± 1.40 | 78.14 ± 4.01 | 85.94 ± 3.32 | 0.0221 | 0.0142 | 0.5763 |
Stage 1 (min) | 29.00 ± 7.97 | 22.67 ± 3.92 | 20.39 ± 2.50 | 0.5416 | ||
Stage 2 (min) | 231.08 ± 9.87 | 217.28 ± 15.17 | 238.56 ± 7.53 | 0.2371 | ||
Stage 3 (min) | 18.58 ± 1.42 | 19.83 ± 2.53 | 22.06 ± 2.60 | 0.6210 | ||
Stage 4 (min) | 77.83 ± 10.37 | 51.83 ± 5.11 | 63.31 ± 9.97 | 0.1667 | ||
REM (min) | 120.17 ± 13.10 | 85.50 ± 9.17 | 92.67 ± 9.73 | 0.1168 | ||
NREM (S2 + S3 + S4) (min) | 327.50 ± 12.64 | 288.94 ± 17.00 | 323.92 ± 12.09 | 0.0476 | 0.0771 | 0.9973 |
SWS (S3 + S4) (min) | 96.42 ± 9.71 | 71.67 ± 5.46 | 85.37 ± 10.57 | 0.1982 | ||
Sleep onset latency (min) | 13.27 ± 5.76 | 14.37 ± 2.33 | 10.59 ± 1.89 | 0.6643 | ||
REM onset latency (min) | 59.25 ± 11.21 | 103.28 ± 20.78 | 72.00 ± 4.05 | 0.0907 | ||
WASO (min) | 22.42 ± 5.80 | 73.00 ± 21.43 | 37.39 ± 17.64 | 0.0237 | 0.0338 | 0.9147 |
Data represent mean ± SEM. Data were subjected to repeated-measures one-factor (Group) mixed-model ANOVA. If a significant main effect was observed, the analysis was followed by Dunnett’s multiple-comparison tests to assess differences between intervention and baseline groups relative to the comparator group.